Global, regional, and national burden of endometriosis among women of reproductive age, 1990–2021: Insights from the global burden of disease study 2021
PLOS One · 26.11.2025 · 20 (11) · e0337074
DOI: 10.1371/journal.pone.0337074 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 26.11.2025. Verfasst von Jun Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of obstetrics and gynecology, first affiliated hospital of dalian medical university, dalian, china. Hauptthemen laut MEDLINE: Endometriosis, Global Burden of Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endometriosis is a common gynecological disorder among women of reproductive age worldwide. This study aims to examine global patterns of endometriosis disease burden among reproductive-aged women and to evaluate its correlation with socioeconomic development indices.
Methods
This study conducted a comprehensive analysis of endometriosis disease burden using epidemiological parameters from the Global Burden of Disease (GBD) 2021 database, including incidence rates, prevalence rates, Disability-Adjusted Life Years (DALYs), and corresponding age-standardized rates. Through stratified analyses at global, regional, and national levels, we systematically evaluated the disease burden patterns among reproductive-aged women and performed correlation analysis with socioeconomic development indices.
Results
We found that the highest incidence of endometriosis among women of reproductive age globally occurs in the 20–24 age group, with an incidence rate of 399.49 per 100,000 in 1990 and 304.31 per 100,000 in 2021. The results show that the global disease burden of endometriosis is mainly influenced by population size, followed by epidemiological changes. Compared to countries with a medium Social Development Index (SDI), the disease burden of endometriosis in low and high SDI regions fluctuated significantly from 1990 to 2021. In most countries with SDI values between 0.2 and 0.6, the burden of endometriosis showed a gradual decline.
Conclusion
Endometriosis remains a significant public health issue for women of reproductive age globally. Although the global disease burden of endometriosis among women of reproductive age showed a slight decline from 1990 to 2021, the disease burden continues to fluctuate in certain regions and countries. In light of the differences in the disease burden of endometriosis across regions and countries, regionalized disease management strategies are expected to be developed in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of obstetrics and gynecology, first affiliated hospital of dalian medical university, dalian, china.
- Department of rheumatology and immunology, first affiliated hospital of dalian medical university, dalian, china.
ORCID-Profile: Ling Li
Zitieren
APA
Zhang, J., Pang, M., Li, L., & Guo, C. (2025). Global, regional, and national burden of endometriosis among women of reproductive age, 1990–2021: Insights from the global burden of disease study 2021. PLOS One, 20(11), e0337074. https://doi.org/10.1371/journal.pone.0337074
Vancouver
Zhang J, Pang M, Li L, Guo C. Global, regional, and national burden of endometriosis among women of reproductive age, 1990–2021: Insights from the global burden of disease study 2021. PLOS One. 2025;20(11):e0337074. doi:10.1371/journal.pone.0337074
BibTeX
@article{Zhang2025,
author = {Zhang, Jun and Pang, Mengduan and Li, Ling and Guo, Chuanjia},
title = {Global, regional, and national burden of endometriosis among women of reproductive age, 1990–2021: Insights from the global burden of disease study 2021},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {11},
pages = {e0337074},
doi = {10.1371/journal.pone.0337074}
}
EUVIMED